Review Article on Epithelial Ovarian Cancer with Peritoneal Metastasis


Introduction: Many advances have emerged in the management of peritoneal metastases of ovarian cancer origin, widely known as the most common gynaecological malignancy. This review is an update of the current management algorithm of peritoneal carcinomatosis of ovarian cancer, including screening methods, biomarkers and surgical techniques, in an effort to shed some light into this difficult to treat malignancy.
Objective: To assess awareness in the management of epithelial ovarian cancer (EOC) with peritoneal metastasis with updated therapeutic standpoints.


Ovarian, cancer, chemotherapy, intraperitoneal chemotherapy, upfront surgery, visceral segmental serosectomy (VSS), peritoneal cancer index (PCI), small bowel, carcinomatosis, cytoreductive surgery, ovarian cancer, CA125, screening, debulking, immunotherapy, residual tumor, malignant ascites

Get access to the full version of this article.

Article Info

Article Type
Review Article
Publication history
Received: Tue 04, Oct 2022
Accepted: Tue 18, Oct 2022
Published: Fri 21, Oct 2022
© 2023 K. Grammatikakis. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.COR.2022.04.03

Author Info

Corresponding Author
K. Grammatikakis
Department of Obstetrics and Gynecology, Gynecologic Oncology Program, “TZANEIO” General Hospital, Piraeus, Greece

Figures & Tables

Get access to the full version of this article.